Using engineered cells to treat Alzheimer's disease
Official title: Regulated gene circuits for Alzheimer's disease therapy
Funded at Vanderbilt University · NIH-10871284 · Data updated 2026-11-12
This study is exploring new ways to treat Alzheimer's disease by using specially modified brain cells that can adapt to the changes caused by the disease, with the hope of better protecting the brain and slowing down its decline.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | April 15, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $430,884 |
| NIH project number | 1R21AG086883-01 |
| Project ID | NIH-10871284 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those showing early signs of cognitive decline associated with the condition.
✕Less likely to help
Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
What this research studies
This research investigates innovative approaches to treat Alzheimer's disease by utilizing genetically engineered astrocytes and microglia. These cells are designed to respond dynamically to the disease's progression, potentially enhancing neuroprotection and combating neurodegeneration. The project aims to develop methods that allow these cells to coordinate their protective behaviors based on the specific pathological signatures present in the brain. By focusing on cell-based therapies, the research seeks to address the limitations of current treatments that primarily target neurotransmitter imbalances.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly slow down or even reverse the progression of Alzheimer's disease.
How similar studies have gone: While there have been various attempts to use cell-based therapies for neurodegenerative diseases, this specific approach using engineered astrocytes and microglia is relatively novel and has not been extensively tested.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Brunger, Jonathan Matthew — Vanderbilt University
- Study coordinator: Brunger, Jonathan Matthew
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.